Published in Med Clin (Barc) on March 11, 1995
[Sabbatical leave: vacation or work?]. Med Clin (Barc) (1996) 0.75
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. Br J Clin Pharmacol (2000) 1.55
Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther (1999) 1.49
Success and failure at inpatient heroin detoxification. Br J Addict (1989) 1.48
Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males. Drug Alcohol Depend (2001) 1.22
Psychotropic drug consumption and other factors associated with heroin overdose. Drug Alcohol Depend (1994) 1.20
Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics. Psychopharmacology (Berl) (2004) 1.20
Alcohol and cocaine interactions in humans. J Pharmacol Exp Ther (1993) 1.11
Neuropsychological performance in opiate addicts after rapid detoxification. Drug Alcohol Depend (1987) 1.02
Evaluation of urinary elimination of N-acetyl-beta-glucosaminidase in healthy volunteers treated with dibekacin or gentamicin. Antimicrob Agents Chemother (1982) 0.98
Quantification of 3,4-methylenedioxymetamphetamine and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorus detection. J Chromatogr B Biomed Sci Appl (1999) 0.97
Sensation seeking amongst healthy volunteers participating in phase I clinical trials. Br J Clin Pharmacol (1995) 0.96
Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism. J Pharmacol Exp Ther (1997) 0.96
Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial. Br J Addict (1990) 0.93
Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects. Br J Addict (1992) 0.93
[The consumption of drugs in Spain and its position in European context]. Med Clin (Barc) (1993) 0.84
Pharmacokinetic considerations in abuse liability evaluation. Br J Addict (1991) 0.83
The effects of HIV infection on the development of methadone maintenance treatment in Spain. Addiction (1994) 0.82
Immunomodulating activity of MDMA. Ann N Y Acad Sci (2000) 0.82
Alcoholism among inpatients in a general hospital in Barcelona, Spain. Int J Addict (1988) 0.82
Flunitrazepam consumption among heroin addicts admitted for in-patient detoxification. Drug Alcohol Depend (1993) 0.82
A comparison of the acute behavioral effects of flunitrazepam and triazolam in healthy volunteers. Psychopharmacology (Berl) (1996) 0.81
Efficacy of clonidine and of methadone in the rapid detoxification of patients dependent on heroin. Clin Pharmacol Ther (1985) 0.81
[Medicina Clinica (1992-1993) seen through the Science Citation Index]. Med Clin (Barc) (1997) 0.81
Effect of quinolones on caffeine disposition. Clin Pharmacol Ther (1989) 0.81
Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart. Psychopharmacology (Berl) (2012) 0.81
Response patterns of the Spanish version of the 49-item short form of the Addiction Research Center Inventory after the use of sedatives, stimulants, and opioids. Drug Alcohol Depend (1999) 0.80
Abuse liability of flunitrazepam among methadone-maintained patients. Psychopharmacology (Berl) (1998) 0.79
[Heroin: a new cause of toxicological emergencies]. Med Clin (Barc) (1984) 0.79
Effects of morphine in postaddict humans: a meta-analysis. Drug Alcohol Depend (1994) 0.79
[The risk factors in death from heroin]. Med Clin (Barc) (1995) 0.79
Spanish version of the 49-item short form of the Addiction Research Center Inventory (ARCI). Drug Alcohol Depend (1994) 0.78
Monitoring cocaine epidemics in Barcelona. Lancet (1987) 0.77
Acetylation phenotype and hepatotoxicity in the treatment of tuberculosis in children. Pediatrics (1986) 0.76
Quantification of amphetamine plasma concentrations by gas chromatography coupled to mass spectrometry. J Pharm Biomed Anal (1999) 0.76
Determination of cocaine and its metabolites in human urine by gas chromatography/mass spectrometry after simultaneous use of cocaine and ethanol. J Pharm Biomed Anal (1995) 0.76
[Evaluation activities a symptom of good health]. Med Clin (Barc) (1999) 0.75
[Toxicity of ecstasy]. Med Clin (Barc) (1998) 0.75
Volunteering for research. Lancet (1992) 0.75
Comment: use and abuse of flunitrazepam. Ann Pharmacother (1998) 0.75
[External and institutional control of clinical research]. Med Clin (Barc) (1994) 0.75
[Cardiovascular and neuropsychologic changes during detoxification of heroin addicts with clonidine]. Med Clin (Barc) (1984) 0.75
Double blind assessment of buprenorphine withdrawal in opiate-addicts. NIDA Res Monogr (1990) 0.75
[Toxicologic research in Spain as seen through the databases (1985-1986)]. Med Clin (Barc) (1988) 0.75
Human drug abuse liability: testing times ahead. Br J Addict (1991) 0.75
Simultaneous detection in urine of cocaine and its main metabolites. J Pharm Biomed Anal (1990) 0.75
[Outcome of a sample of heroin addicts 2 years after the beginning of treatment (project EMETHYST)]. Med Clin (Barc) (1989) 0.75
[Why does one become addicted to heroin?]. Med Clin (Barc) (1984) 0.75
[Cocaine: the epidemic to come]. Med Clin (Barc) (1988) 0.75
[Pathological processes in 176 heroin addicts admitted at a general hospital]. Med Clin (Barc) (1984) 0.75
[Treatment of acute pain in a general hospital: opinions of physicians and nurses]. Rev Clin Esp (1992) 0.75
[Acute fatal poisoning caused by methylenedioxyamphetamine]. Med Clin (Barc) (1996) 0.75
[Is the incidence of heroin addiction diminishing in Spain?]. Med Clin (Barc) (1988) 0.75
Buprenorphine versus heroin dependence: comparison of toxicologic and psychopathologic characteristics. Am J Psychiatry (1993) 0.75
[Prioritization of biomedical research: implications for investigation in public health and health services]. Gac Sanit (2001) 0.75
[Rehabilitation of heroin addicts: definition, criteria and problems of evaluation and follow-up studies]. Med Clin (Barc) (1986) 0.75
Diclofenac versus dipyrone in acute renal colic: a double-blind controlled trial. Eur J Clin Pharmacol (1987) 0.75
More on opioid overdose. Addiction (1999) 0.75
[Acute poisonings in Barcelona. Epidemiology and therapeutic considerations (author's transl)]. Med Clin (Barc) (1980) 0.75
Heroin intoxication: the relation between plasma morphine concentration and clinical state at admission. Eur J Clin Pharmacol (1991) 0.75
Proficiency testing on drugs of abuse: one year's experience in Spain. Clin Chem (1989) 0.75
Detection and quantification of non-steroidal anti-inflammatory agents by gas chromatography/mass spectrometry: diclofenac. Biomed Environ Mass Spectrom (1988) 0.75
[International diffusion of Spanish research on drug dependence]. Med Clin (Barc) (1988) 0.75
[Clinical effectiveness of naloxone in acute ethanol intoxication]. Rev Clin Esp (1993) 0.75